Gil Azulay

Gil Azulay currently serves as the Business Development Lead at Quris AI since July 2024. Previously, Gil held the position of BD&L Senior Analyst at Medison Pharma from March 2022 to July 2024, where responsibilities included leading partnership efforts in hematology by identifying and evaluating investment opportunities. Between October 2020 and March 2022, Gil worked as a Business Development Analyst and Senior Scientist at Trobix Bio, focusing on pre-clinical lab experiments and contributing to R&D and marketing initiatives. Prior experience includes serving on the science team at D-MARS from January 2019 to October 2020 and a range of academic roles at Tel Aviv University, including lecturer and research assistant from October 2013 to October 2020. Gil holds a PhD in Biomedicine and Cancer Research, an MBA in Business Administration, and a Master's in Molecular Cell Biology and Biotechnology, all from Tel Aviv University.